O-021Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability–high (MSI-H) colorectal cancer: KEYNOTE-164. (20th June 2018) - Le, D; Kavan, P; Kim, T; Burge, M; Van Cutsem, E; Hara, H; Boland, P; Van Laethem, J; Geva, R; Taniguchi, H; Crocenzi, T; Sharma, M; et al.